- 01Berberine moves lab numbers more than it moves the scale
In pooled trials, berberine lowered triglycerides by about 24 mg/dL and HOMA-IR (a score of insulin resistance) by about 1 point, while weight fell by under 1 kg 4. So the place to look for an effect is fasting glucose, fasting insulin and triglycerides; the scale will barely register it.
The trials on berberine and weight add up to about 2 pounds (0.88 kg) over several months, and that number has shrunk as more trials have come in. Berberine is a bitter yellow compound from barberry and goldenseal roots; our berberine guide covers what it is, its forms and its full interaction list. This page covers what berberine does to body weight, belly fat and liver fat, how that compares with the treatments that do move weight, and how to tell whether it is doing anything for you.
How much weight do people lose on berberine?
People in berberine trials lost about 1 to 2 kg more than people on placebo, and the most recent and largest analysis puts it at the low end. In 2026, Elahi Vahed and colleagues pooled 23 randomized trials in the International Journal of Obesity: berberine lowered body weight by 0.88 kg, BMI by 0.48 and waist size by about 1.3 cm compared with control, and it did not change waist-to-hip ratio 1. For a 90 kg (198 lb) adult, 0.88 kg is about 1% of body weight.
| Analysis | Trials or people | Who was studied | What was given | Weight vs control |
|---|---|---|---|---|
| Asbaghi, 2020 3 | 12 randomized trials | Adults, mostly with metabolic disease | Mixed doses and products | Down 2.07 kg; waist down 1.08 cm |
| Zamani, 2022 4 | Dose-response pooling | Adults, cardiovascular risk factors | Best effect near 1 g a day | Down 0.84 kg |
| Elahi Vahed, 2026 1 | 23 randomized trials | Adults | Mixed doses and products | Down 0.88 kg; waist down about 1.3 cm; waist-to-hip ratio unchanged |
| Lei (BRAVO), 2026 2 | 337 people, one placebo trial | Adults with obesity and fatty liver, no diabetes | 1 g a day for 6 months | No change in belly fat or liver fat on CT |
The figure probably fell from about 2 kg to under 1 kg because many early trials were small and short, and the 2026 review flagged common problems with blinding (people knowing whether they were taking berberine) and randomization, which tend to overstate an effect. The 2026 authors asked future trials to report the purity, potency and gram amounts of the berberine they used, and to fix those lapses 1. The US National Center for Complementary and Integrative Health (NCCIH) adds that most participants had diabetes or fatty liver, most trials ran in Asia, and weight effects showed up mainly above 1 g a day and beyond 8 weeks 9.
Does berberine burn belly fat or liver fat?
Berberine did not reduce belly fat or liver fat in the best trial that has measured them. The BRAVO trial, published in JAMA Network Open in January 2026, randomly assigned 337 adults with obesity and metabolic dysfunction-associated fatty liver disease (MASLD), none with diabetes, to berberine 1 g a day or a matching placebo for 6 months 2. CT scans measured visceral fat (the fat packed around the organs, explained in our visceral fat guide) and liver fat. Neither moved more on berberine than on placebo. It did lower LDL cholesterol by about 7.7 mg/dL and apoB (a count of the cholesterol particles that can clog arteries) by about 3.4 mg/dL more than placebo 2.
A 6-month berberine treatment at a daily dose of 1 g had an excellent safety profile but did not reduce VAT area or liver fat content.Lei and colleagues, BRAVO trial, JAMA Network Open, 2026 (VAT is visceral adipose tissue, the belly fat around the organs) 2
BRAVO matters because these are the people berberine is supposed to help most: heavy, with a fatty liver, and metabolically unhealthy. Adherence was about 90% in both groups 2, so the null result cannot be blamed on people skipping capsules. If your interest is liver fat, our fatty liver guide covers the blood tests that track it. If you want to know your own visceral fat, a DEXA scan measures it without the radiation dose of CT.
Is berberine "nature's Ozempic"?
No. The weight lost on berberine is about one fourteenth of what semaglutide (the drug in Ozempic and Wegovy) produced in its main trial, and it sits below what metformin or a structured lifestyle program achieved in the Diabetes Prevention Program (DPP), a large US trial in people at high risk of diabetes 6.
| Option | Average weight change | Trial length | How it is given | Regulated as | Reaches the 3 to 5% line? |
|---|---|---|---|---|---|
| Placebo (DPP) | Down 0.1 kg 6 | About 2.8 years | Pill | Not applicable | No |
| Berberine | Down 0.88 kg more than control, about 1% 1 | Mostly a few months | Capsules split across meals | Dietary supplement | No |
| Metformin (DPP) | Down 2.1 kg, about 2% 6 | About 2.8 years | Tablets, prescribed | Prescription drug, not approved for weight | No (about 2%) |
| Intensive lifestyle (DPP) | Down 5.6 kg, about 6% 6 | About 2.8 years | Diet and activity coaching | Program | Yes |
| Semaglutide 2.4 mg, sold as Wegovy (STEP 1) | Down 14.9% vs 2.4% on placebo 5 | 68 weeks | Weekly injection | Prescription drug approved for weight | Yes |
The mechanisms differ too. Semaglutide acts on appetite centers in the brain and slows stomach emptying, which is why people eat less on it; our retatrutide vs semaglutide comparison covers how the newer drugs compare. We found no human trial showing that berberine suppresses appetite.
The prescription comparison people ask about
If the question in your head is berberine or metformin, our berberine vs metformin comparison puts it plainly: stopping metformin for berberine trades a medicine with outcome evidence for a supplement without it, and berberine changes how many other drugs are cleared.
How berberine is thought to work
Berberine switches on AMPK, an enzyme that acts as the cell's fuel gauge, and that lowers how much glucose the liver releases. Most of that mechanism comes from preclinical work. In people, the measured effects are lower fasting glucose, lower HOMA-IR and lower triglycerides in pooled trials 4. Much of a swallowed dose stays in the gut, and human data on a gut-bacteria route are thin. None of these pathways has produced more than about 1 kg of weight loss in people. The berberine guide covers the mechanism and the forms in more depth.
Where the trial effects were largest
Most berberine trials enrolled people whose blood sugar or triglycerides already ran high, including people with type 2 diabetes, prediabetes, insulin resistance and PCOS. In a 2022 dose-response analysis of those trials, fasting glucose was about 7.7 mg/dL lower, HOMA-IR about 1.0 lower, HbA1c (a three-month blood sugar average) about 0.45 points lower, triglycerides about 23.7 mg/dL lower and total cholesterol about 20.6 mg/dL lower than control, against 0.84 kg of weight 4. Most of the change shows up in those lab markers; weight barely moves. These are averages from research groups, not a treatment for any of these conditions; each is diagnosed and managed by a clinician, and berberine is not a substitute for that care.
Because most participants had diabetes or fatty liver 9, there is little trial evidence in people with normal blood sugar and a healthy liver, and nothing in the data suggests they would lose more.
The markers berberine moves more than weight
If you have diabetes, take insulin or a sulfonylurea (such as glipizide or gliclazide), or use a GLP-1 drug, berberine is a conversation for your prescriber, because it adds to the glucose-lowering effect of those medicines. With insulin or a sulfonylurea, low blood sugar is the risk to know about; see low blood sugar.
Berberine dosage for weight loss: what the trials used
Most weight trials split the daily amount into two or three doses taken with or shortly before meals. The dose-response analysis found the best weight effect near 1 g a day 4, and NCCIH notes the weight effects appeared mainly above 1 g a day and beyond 8 weeks 9. Those are the study conditions, and this page does not give a dose; our berberine guide compares the HCl, phytosome and dihydroberberine forms.
How berberine was taken in the weight trials
If you and your clinician decide to try it, the trials suggest a fair test looks like this.
- 1Check your medicines firstAsk a pharmacist or prescriber whether any prescription you take is cleared by CYP3A4, CYP2D6 or CYP2C9, the enzymes berberine slows 8. If you take insulin or a sulfonylurea, berberine can push blood sugar too low: shakiness, sweating, confusion or a racing heart need treating straight away. Yellow skin or eyes or dark urine need prompt medical care.
- 2Take a baselineFasting glucose, fasting insulin, HbA1c and triglycerides, ideally ordered or reviewed by your clinician, plus waist and weight; the waist-to-height calculator turns a tape measure into a number you can track. If fasting glucose or HbA1c is already in the prediabetes or diabetes range, or ALT is above the lab's range, take it to a clinician before trying any supplement: those results need a diagnosis, not an experiment.
- 3Give it timeTrials saw weight effects mainly beyond 8 weeks 9, and HbA1c reflects about 3 months, so about 12 weeks is a practical first check. The dose-response analysis found glucose effects were largest in trials lasting about 40 weeks 4, so a 12-week check shows direction, not the full effect.
- 4Retest the same waySame fasting time, same lab if you can, same time of day; our fasting before a blood test guide covers the details.
- 5Review the results with your clinicianIf weight, waist and those markers have not changed after about 12 weeks, the trial evidence gives no reason to expect much more; go over the results with your clinician before deciding whether to continue. If ALT rises on retest, stop and see a clinician.
Side effects and who should skip it
Digestive complaints are the side effects reported most often with berberine: nausea, abdominal pain, bloating, constipation and diarrhea 9. The bigger risk is interactions. Two weeks of berberine at 300 mg three times a day slowed CYP2D6, CYP2C9 and CYP3A4, three liver enzymes that clear many prescription drugs, in healthy men 8; one result was 27% slower clearance of midazolam, a sedative. The berberine guide lists and sources the full set of interactions, including cyclosporine, an anti-rejection drug.
Supplements are not reviewed by the FDA for safety or effectiveness before sale, and the FDA has found hidden prescription drugs in products sold for weight loss. A berberine product with a third-party testing seal (such as USP or NSF) at least confirms the label matches the capsule.
Link · US Food and Drug AdministrationTainted weight loss productsThe FDA's list of weight-loss supplements found to contain hidden drug ingredients.fda.govHow to tell if it's working: the labs to check
Because berberine moves lab markers more than weight, a before-and-after set of blood tests shows more than the scale. With your clinician, check the same panel at the start and after about 12 weeks, fasted for the same number of hours both times: fasting glucose, fasting insulin (so you can work out HOMA-IR), HbA1c, triglycerides with HDL (for the triglyceride to HDL ratio) and ALT, a liver enzyme. A real response looks like several of those moving the same way, with triglycerides and HOMA-IR falling, rather than one number shifting on its own, which can be day-to-day noise (why trends beat single readings). If you have diabetes or fatty liver, these results belong in your regular care, not a self-run trial.
CalculatorHOMA-IR calculatorTurn your fasting glucose and fasting insulin into a HOMA-IR score at baseline and again at 12 weeks.Work it out Free, no accountRead your blood testHave your fasting glucose, insulin and lipid results from before and after 12 weeks? Read every line of both reports, free.Read my results 
What moves weight more than berberine
The interventions with the largest, best-tested effect on weight are a sustained calorie deficit with enough protein, regular activity, enough sleep, a structured lifestyle program, and, for people who qualify, prescription medicines. In the Diabetes Prevention Program, 3,234 adults at high risk of diabetes were followed for an average of 2.8 years; the lifestyle group lost 5.6 kg and cut new diabetes by 58%, against 2.1 kg and 31% on metformin 6.
The TDEE calculator estimates the calories that hold your weight, and the protein calculator gives a daily protein target that helps keep muscle while you lose fat. Our weight loss hub brings the calculators, markers and guides together. On the evidence so far, berberine belongs at the end of that list: its weight effect is small, and any use alongside a health condition or medicine is a decision to make with your clinician.
Citations
- Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53-73.
- Lei L, Wang B, Zhao L, et al; BRAVO Collaborative Group. Berberine and adiposity in diabetes-free individuals with obesity and MASLD: a randomized clinical trial. JAMA Netw Open. 2026;9(1):e2554152.
- Asbaghi O, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:43-49.
- Zamani M, et al. The effects of berberine supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. Front Nutr. 2022;9:1013055.
- Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.
- Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
- Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation. 2014;129(25 Suppl 2):S102-S138.
- Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217.
- National Center for Complementary and Integrative Health. Berberine and weight loss: what you need to know. National Institutes of Health.
- Harrison SA, et al. A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nat Commun. 2021;12:5503.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.







